Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells.

[1]  A. Crisanti,et al.  Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells , 2017, European Journal of Nutrition.

[2]  G. Cerulli,et al.  β-NGF and β-NGF receptor upregulation in blood and synovial fluid in osteoarthritis , 2017, Biological chemistry.

[3]  A. Drilon,et al.  Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). , 2017, Cancer discovery.

[4]  C. Pincelli.  p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function , 2017, Front. Med..

[5]  T. Redmer,et al.  The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells , 2017, Oncogenesis.

[6]  G. Cerulli,et al.  Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression. , 2016, Journal of Alzheimer's disease : JAD.

[7]  C. Simopoulos,et al.  Development of a Novel Experimental In Vitro Model of Isothiocyanate-induced Apoptosis in Human Malignant Melanoma Cells. , 2016, Anticancer research.

[8]  R. Eckert,et al.  The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane , 2016, Molecular carcinogenesis.

[9]  G. Grisendi,et al.  downregulation promotes melanoma progression and invasion in 3-dimensional models and in zebrafish , 2016 .

[10]  T. Gambichler,et al.  Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma , 2016, Clinical and experimental dermatology.

[11]  M. Bothwell,et al.  Open Peer Review Recent Advances in Understanding Neurotrophin Signaling [version 1; Referees: 2 Approved] , 2022 .

[12]  Samantha E. Boyle,et al.  CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity. , 2016, Cancer research.

[13]  J. Coombes,et al.  Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? , 2016, Oxidative medicine and cellular longevity.

[14]  A. Quattrone,et al.  TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines , 2015, BMC Cancer.

[15]  C. Montagnoli,et al.  LY294002 induces in vitro apoptosis and overexpression of p75NTR in human uterine leiomyosarcoma HTB 114 cells , 2015, Growth factors.

[16]  C. Fimognari,et al.  Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species , 2015, BioMed research international.

[17]  N. Mottet,et al.  Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy , 2015, Cancer Prevention Research.

[18]  C. Longo,et al.  Hypoxia‐Inducible Factor‐1α and CD271 inversely correlate with melanoma invasiveness , 2015, Experimental dermatology.

[19]  M. Mori,et al.  A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer , 2015, Investigational New Drugs.

[20]  Changhao Sun,et al.  Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention , 2014, PloS one.

[21]  David E. Fisher,et al.  The melanoma revolution: From UV carcinogenesis to a new era in therapeutics , 2014, Science.

[22]  Xiuli Guo,et al.  The role of nerve growth factor and its receptors in tumorigenesis and cancer pain. , 2014, Bioscience trends.

[23]  A. Olszanski.  Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma , 2014, Journal of managed care & specialty pharmacy.

[24]  C. Montagnoli,et al.  The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75NTR-dependent apoptosis , 2013, Anti-cancer drugs.

[25]  C. Montagnoli,et al.  Antiproliferative and Proapoptotic Effects of the TrK-inhibitor GW441756 in Human Myosarcomas and Prostatic Carcinoma , 2013 .

[26]  G. Ichim,et al.  Neurotrophins and cell death. , 2012, Experimental cell research.

[27]  A. Gorman,et al.  Nerve Growth Factor in Cancer Cell Death and Survival , 2011, Cancers.

[28]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[29]  Irving L. Weissman,et al.  Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.

[30]  C. Montagnoli,et al.  Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: An immunohistochemical and ultracytochemical study , 2010, The Prostate.

[31]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  L. French,et al.  Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. , 2008, The Journal of investigative dermatology.

[33]  P. Hrelia,et al.  Sulforaphane as a promising molecule for fighting cancer. , 2007, Mutation research.

[34]  N. Juge,et al.  Molecular basis for chemoprevention by sulforaphane: a comprehensive review , 2007, Cellular and Molecular Life Sciences.

[35]  L. Reichardt,et al.  Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[36]  G. Ugolini,et al.  Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study , 2006, Anti-cancer drugs.

[37]  G. Kuttan,et al.  Antimetastatic activity of Sulforaphane. , 2006, Life sciences.

[38]  J. Arevalo,et al.  Neurotrophin signaling: many exciting surprises! , 2006, Cellular and Molecular Life Sciences CMLS.

[39]  V. A. Flørenes,et al.  Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome. , 2004, American journal of clinical pathology.

[40]  Rebecca Aucoin,et al.  Brain metastases in melanoma: roles of neurotrophins. , 2004, Neuro-oncology.

[41]  E. Alleva,et al.  Stress and nerve growth factor Findings in animal models and humans , 2002, Pharmacology Biochemistry and Behavior.

[42]  Philippe P Roux,et al.  Neurotrophin signaling through the p75 neurotrophin receptor , 2002, Progress in Neurobiology.

[43]  G. Nicolson,et al.  Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. , 1993, Molecular biology of the cell.

[44]  V. Hamburger,et al.  Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. , 1951, The Journal of experimental zoology.

[45]  C. Montagnoli,et al.  A role for NGF and its receptors TrKA and p75NTR in the progression of COPD , 2016, Biological chemistry.

[46]  K. Fung,et al.  Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain. , 2014, International journal of clinical and experimental pathology.

[47]  S. Skaper.  The neurotrophin family of neurotrophic factors: an overview. , 2012, Methods in molecular biology.